Resultado da Busca
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American financial criminal and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals , and the former CEO of start ...
- Released
- Hunter College High School
- 7 years in prison (paroled after 6 years and 5 months), $72 million in fines
11 de mar. de 2018 · O americano Martin Shkreli, acusado de explorar os mais pobres, não conseguiu evitar as lágrimas quando teve de ler a sentença que o deixará sete anos na prisão. Nascido no Brooklyn, em Nova...
14 de jan. de 2022 · Martin Shkreli, the former pharmaceutical executive best known for unapologetically hiking the price of a lifesaving medication, must pay $64.6 million and will be barred for life from the drug...
19 de mai. de 2022 · Martin Shkreli, a former pharmaceutical executive known for raising the price of a life-saving drug by 5,000%, was released from prison and transferred Wednesday to community confinement, the...
- Rina Torchinsky
18 de mai. de 2022 · Maya Yang. Wed 18 May 2022 16.13 EDT. Martin Shkreli, the “Pharma Bro” entrepreneur who astronomically increased the price of a life-saving drug by 5,000%, and became a symbol of corporate Wall...
- Maya Yang
14 de jan. de 2022 · NEW YORK — Martin Shkreli must return $64.6 million in profits that he and his former company reaped from raising the price of the lifesaving drug Daraprim, a federal judge ruled Friday, while...
18 de mai. de 2022 · NEW YORK, May 18 (Reuters) - Martin Shkreli, the former pharmaceutical executive known for raising the price of a lifesaving drug more than 40-fold, has been released from prison, where he had...
